Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Starke JeffEVP, CHIEF INFORMATION OFFICER |  RBCAAREPUBLIC BANCORP INC /KY/Option exercise | M | — 6,720 sh | Oct 29, 2026 |
| 5 | Starke JeffEVP, CHIEF INFORMATION OFFICER | RBCAAREPUBLIC BANCORP INC /KY/ Grant or award | A | — 10 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 5 | O'Brien Kevin PatrickChief Financial Officer |  HYFMHYDROFARM HOLDINGS GROUP, INC.Grant or award | A | — 55.2K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 5 | Pullin Ericka LynnGEVP, Culture & People Dev. |  CFRCULLEN/FROST BANKERS, INC.Grant or award | A | — 1,666 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $512K 1,440 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $443K 1,239 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Eisen Anthony MathewDirector |  XYZBlock, Inc.Open-market sale · 10b5-1 plan | SELL | $447K 6,000 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 4 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $336K 11.9K sh | Oct 29, 2026 traded Oct 29, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $313K 880 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $460K 1,280 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Boughton SoleilChief Legal Officer |  HIMSHims & Hers Health, Inc.Open-market sale · 10b5-1 plan | SELL | $96K 3,462 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 4 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $332K 11.7K sh | Oct 29, 2026 traded Oct 28, 2026 |
| 3 | Cheng Chi FungDirector, Chief Technology Officer |  CRDOCredo Technology Group Holding LtdOpen-market sale · 10b5-1 plan | SELL | $31K 200 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 3 | Twomey Christopher JDirector |  TNDMTANDEM DIABETES CARE INCOption exercise · 10b5-1 plan | M | $32K 1,700 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 3 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $48K 300 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 3 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $32K 200 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $244K 8,881 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 1 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $115K 320 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 1 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Option exercise · 10b5-1 plan | M | $1.14M 31.0K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $80K 3,000 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Hafer EvanDirector, Founder, 10% Owner |  BRCCBRC Inc.Other acquisition or disposition · 10b5-1 plan | J | — 12.0K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Hafer EvanDirector, Founder, 10% Owner | BRCCBRC Inc. Derivative conversion · 10b5-1 plan | C | — 12.0K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Twomey Christopher JDirector | TNDMTANDEM DIABETES CARE INC Option exercise · 10b5-1 plan | M | — 1,700 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Hafer EvanDirector, Founder, 10% Owner | BRCCBRC Inc. Derivative conversion · 10b5-1 plan | C | — 12.0K sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $5,780 200 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Oct 29, 2026 traded Oct 29, 2026 |
| 0 | Hafer EvanDirector, Founder, 10% Owner | BRCCBRC Inc. Derivative conversion · 10b5-1 plan | C | — 12.0K sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Hafer EvanDirector, Founder, 10% Owner | BRCCBRC Inc. Other acquisition or disposition · 10b5-1 plan | J | — 12.0K sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Oct 29, 2026 traded Oct 29, 2026 |
| 0 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Option exercise · 10b5-1 plan | M | — 403.4K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Buczkowski MichelleChief Commercial Officer |  EOSEEos Energy Enterprises, Inc.Option exercise · 10b5-1 plan | M | — 100.0K sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 | Sarowitz Steven IDirector, 10% Owner |  PCTYPaylocity Holding CorpOpen-market sale · 10b5-1 plan | SELL | $17K 100 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 | Robinhood Markets, Inc.10% Owner |  RVIRobinhood Ventures Fund IOpen-market sale · 10b5-1 plan | SELL | $4,725 189 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Hafer EvanDirector, Founder, 10% Owner | BRCCBRC Inc. Derivative conversion · 10b5-1 plan | C | — 12.0K sh | Oct 29, 2026 traded Oct 27, 2026 |
| 56 | Polito KarynDirector |  BBTBeacon Financial CorpOpen-market purchase | BUY | $31K 1,000 sh | Oct 28, 2026 traded Oct 26, 2026 |
| 53 | Portman David J.10% Owner |  LONALeonaBio, Inc.Open-market purchase | BUY | $17.33B 5.50M sh | Oct 28, 2026 traded Oct 26, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369KBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K